Emmes to expand biopharma portfolio with appointment of new vice president

Rockville, Maryland-headquartered Clinical Research Organization Emmes has appointed Matt Honan as vice president and global head of corporate development.

In this newly created position, Honan will lead the company in identifying and executing acquisitions that complement Emmes' existing federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach.

Honan served most recently as senior director, M&A and business development, at Quest Diagnostics. There, he led cross-functional teams through the entire M&A lifecycle, executing more than 20 transactions valued at more than $1bn. Prior to assuming that role, he held various M&A and finance positions of increasing responsibility.

As a Presidential Scholar, Matt graduated from George Washington University with a bachelor's degree in mechanical engineering and began his career as an engineer at Stähli USA, Inc. He then attended Rutgers University and obtained his MBA in finance before starting at Quest.